These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34281830)

  • 41. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
    Nishimura K; Ting HJ; Harada Y; Tokizane T; Nonomura N; Kang HY; Chang HC; Yeh S; Miyamoto H; Shin M; Aozasa K; Okuyama A; Chang C
    Cancer Res; 2003 Aug; 63(16):4888-94. PubMed ID: 12941811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
    Mori R; Xiong S; Wang Q; Tarabolous C; Shimada H; Panteris E; Danenberg KD; Danenberg PV; Pinski JK
    Prostate; 2009 Jan; 69(1):12-23. PubMed ID: 18814146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.
    Labrecque MP; Takhar MK; Nason R; Santacruz S; Tam KJ; Massah S; Haegert A; Bell RH; Altamirano-Dimas M; Collins CC; Lee FJ; Prefontaine GG; Cox ME; Beischlag TV
    Oncotarget; 2016 Apr; 7(17):24284-302. PubMed ID: 27015368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis.
    Alexandre D; Hautot C; Mehio M; Jeandel L; Courel M; Voisin T; Couvineau A; Gobet F; Leprince J; Pfister C; Anouar Y; Chartrel N
    Eur J Cancer; 2014 Aug; 50(12):2126-33. PubMed ID: 24910418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
    Ramnarine VR; Alshalalfa M; Mo F; Nabavi N; Erho N; Takhar M; Shukin R; Brahmbhatt S; Gawronski A; Kobelev M; Nouri M; Lin D; Tsai H; Lotan TL; Karnes RJ; Rubin MA; Zoubeidi A; Gleave ME; Sahinalp C; Wyatt AW; Volik SV; Beltran H; Davicioni E; Wang Y; Collins CC
    Gigascience; 2018 Jun; 7(6):. PubMed ID: 29757368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
    Xie S; Lin HK; Ni J; Yang L; Wang L; di Sant'Agnese PA; Chang C
    Prostate; 2004 Jun; 60(1):61-7. PubMed ID: 15129430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
    Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
    Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
    Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
    Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer.
    Crea F; Venalainen E; Ci X; Cheng H; Pikor L; Parolia A; Xue H; Nur Saidy NR; Lin D; Lam W; Collins C; Wang Y
    Epigenomics; 2016 May; 8(5):721-31. PubMed ID: 27096814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gelsolin negatively regulates the activity of tumor suppressor p53 through their physical interaction in hepatocarcinoma HepG2 cells.
    An JH; Kim JW; Jang SM; Kim CH; Kang EJ; Choi KH
    Biochem Biophys Res Commun; 2011 Aug; 412(1):44-9. PubMed ID: 21801713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
    Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
    Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression.
    Lee AR; Li Y; Xie N; Gleave ME; Cox ME; Collins CC; Dong X
    Oncotarget; 2017 Apr; 8(17):27966-27975. PubMed ID: 28427194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure, regulation and related diseases of the actin-binding protein gelsolin.
    Feldt J; Schicht M; Garreis F; Welss J; Schneider UW; Paulsen F
    Expert Rev Mol Med; 2019 Jan; 20():e7. PubMed ID: 30698126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment of prostate cancer spheres from a prostate cancer cell line after phenethyl isothiocyanate treatment and discovery of androgen-dependent reversible differentiation between sphere and neuroendocrine cells.
    Chen Y; Cang S; Han L; Liu C; Yang P; Solangi Z; Lu Q; Liu D; Chiao JW
    Oncotarget; 2016 May; 7(18):26567-79. PubMed ID: 27034170
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
    Meyer-Siegler K
    Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuronal Trans-Differentiation in Prostate Cancer Cells.
    Farach A; Ding Y; Lee M; Creighton C; Delk NA; Ittmann M; Miles B; Rowley D; Farach-Carson MC; Ayala GE
    Prostate; 2016 Oct; 76(14):1312-25. PubMed ID: 27403603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.
    Sun F; Zhang ZW; Tan EM; Lim ZLR; Li Y; Wang XC; Chua SE; Li J; Cheung E; Yong EL
    Carcinogenesis; 2016 Jul; 37(7):701-711. PubMed ID: 27207661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.
    Xiang Q; Zhu Z; Luo L; Wang J; Liu Y; Deng Y; Zhou M; Zhao Z
    Biomed Res Int; 2020; 2020():5395312. PubMed ID: 33029516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.
    Lin TP; Chang YT; Lee SY; Campbell M; Wang TC; Shen SH; Chung HJ; Chang YH; Chiu AW; Pan CC; Lin CH; Chu CY; Kung HJ; Cheng CY; Chang PC
    Oncotarget; 2016 May; 7(18):26137-51. PubMed ID: 27034167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.